What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? (CA-MRSA)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Staphylococcus aureus is the most common bacteria responsible for skin, bone, and muscle infections. Recent studies from the United States have suggested that a type of this bacterium called methicillin resistant S. aureus (MRSA) has become dramatically more common, especially the community strain. However, Canadian data is still largely lacking. This study aims to determine the prevalence of community acquired (CA) MRSA among patients presenting with skin and soft tissue infections to the Urgent Care Center and Emergency Departments in London, Ontario. This will be determined by taking swabs at enrollment from patient's noses, throats, and sites of infection. Patients will be asked to complete a health questionnaire with the goal of identifying risk factors associated with CA-MRSA. Through follow-up swabs of participants' noses and throats at one and three months, the effects of treatment on patient's carrying MRSA will be determined. Results may be used to form guidelines for empirical S aureus treatment in the region, reducing possible morbidity and mortality from delayed or suboptimal treatment of CA-MRSA infections. Improved understanding of risk factors associated with MRSA infection in a Canadian setting, may also change the practice of physicians considering empiric antibiotic therapy for skin and soft tissue infections.
| Condition |
|---|
|
Bacterial Infections Gram-Positive Bacterial Infections Staphylococcal Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Prevalence of MRSA in Skin and Soft Tissue Infections in Two Ontario Emergency Departments. |
| Enrollment: | 152 |
| Study Start Date: | July 2008 |
| Study Completion Date: | November 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Selection of Participants: The objective of this prospective study is to determine the prevalence of MRSA and community acquired MRSA (CA-MRSA) in adult patients (>17 yrs old) presenting with skin or soft tissue infections to the emergency departments (EDs) of an academic health care setting in London, Ontario.
Inclusion Criteria:
- All adult patients (> 17 years) whose chief complaint is consistent with skin or soft tissue infection (cellulitis, necrotizing soft tissue infection, wound infection, ulcer, septic bursitis, abscess including furuncle/carbuncle/superficial skin abscess, paronychia, hordeolum, pilonidal abscess, acute lymphadenitis, pilonidal cyst without abscess, and impetigo).
Exclusion Criteria:
- Patients will be excluded if they refuse to participate or written, informed consent is not obtained.
- Additionally, patients with Bartholin cysts, odontogenic infections and perianal abscesses will be excluded.
Contacts and Locations| Canada, Ontario | |
| London Health Sciences Centre | |
| London, Ontario, Canada, N6A 5W9 | |
| Principal Investigator: | Christopher MB Fernandes, FRCP, FACEP, MD | University of Western Ontario, Canada |
More Information
No publications provided
| Responsible Party: | Dr. Christopher Fernandes, London Health Sciences Centre |
| ClinicalTrials.gov Identifier: | NCT00736554 History of Changes |
| Other Study ID Numbers: | R-08-173, 13871E |
| Study First Received: | August 14, 2008 |
| Last Updated: | January 4, 2011 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by Lawson Health Research Institute:
|
Staphylococcus aureus CA-MRSA skin and soft tissue infections resistance emergency department |
Additional relevant MeSH terms:
|
Bacterial Infections Emergencies Staphylococcal Infections Gram-Positive Bacterial Infections |
Soft Tissue Infections Disease Attributes Pathologic Processes Infection |
ClinicalTrials.gov processed this record on May 21, 2013